FindTrial
Sign In

Endostatin

DRUG6 trials

Sponsors

Sun Yat-sen University, Zhejiang Cancer Hospital, Beijing Tiantan Hospital, Tianjin Medical University Cancer Institute and Hospital, Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Conditions

Advanced Solid TumorEndostatinNasopharyngeal CarcinomaNeurofibromatosis Type 2Non Small Cell Lung CancerNon-small Cell Lung CancerRefractory TumorVestibular Schwannoma

Phase 2

Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer
NCT01218594
Sun Yat-sen UniversityNon-small Cell Lung Cancer
Start: 2009-05-31End: 2015-12-31Updated: 2012-10-17
Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma
NCT01612286
Zhejiang Cancer HospitalNasopharyngeal Carcinoma
Start: 2012-05-31End: 2014-05-31Target: 30Updated: 2014-02-19
Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
CompletedNCT02104323
Beijing Tiantan HospitalNeurofibromatosis Type 2, Vestibular Schwannoma
Start: 2014-01-31End: 2016-04-30Updated: 2017-02-09
Recombinant Human Angioendostatin /PD-1 Mab Combined With First-line Chemotherapy in the Treatment of Driver Gene Negative Advanced NSCLC
NCT05448781
Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityEndostatin, Non Small Cell Lung Cancer
Start: 2022-07-20End: 2023-12-20Target: 38Updated: 2022-07-07
A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer
NCT06047860
Second Affiliated Hospital of Soochow UniversityAdvanced Solid Tumor, Refractory Tumor
Start: 2023-06-16End: 2024-12-31Target: 30Updated: 2023-09-21

Phase 4

Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC
CompletedNCT02497118
Tianjin Medical University Cancer Institute and HospitalNon Small Cell Lung Cancer
Start: 2010-08-31End: 2015-06-30Updated: 2015-07-14

Related Papers

Efficacy and Safety of PRaG Therapy in Elderly Patients with Advanced Malignant Tumors: A Prospective, Multicenter Clinical Study Protocol (PRaG 9.0 Study)
Technology in Cancer Research & Treatment2025-06-01
Combining antiangiogenic therapy with neoadjuvant chemotherapy increases treatment efficacy in stage IIIA (N2) non-small cell lung cancer without increasing adverse effects
Oncotarget2016-08-2318 citations